| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/29/1993 | EP0562956A1 Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them |
| 09/29/1993 | EP0562853A1 29-Demethoxyrapamycin for inducing immunosuppression |
| 09/29/1993 | EP0562439A1 Triazolopyridazines as antioasthmatics |
| 09/29/1993 | EP0562009A1 ENANTIOMERICALLY PURE $g(b)-D-(-)-DIOXOLANE-NUCLEOSIDES |
| 09/29/1993 | EP0561989A1 Compounds that inhibit complement and/or suppress immune activity |
| 09/29/1993 | EP0561973A1 Antiallergic compounds |
| 09/29/1993 | EP0561772A1 A new pharmaceutical use of fusidic acid and derivatives thereof |
| 09/29/1993 | CN1076696A Pharmaceutical compounds |
| 09/28/1993 | US5248695 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in animal feeds |
| 09/28/1993 | US5248693 Acetylene compounds and pharmaceutical compositions and methods of using the same |
| 09/28/1993 | US5248681 Antiinflammatory agents |
| 09/28/1993 | US5248504 Method of treatment for nasal and sinus dysfunction |
| 09/28/1993 | CA2092729A1 Method for inducing immunosuppression |
| 09/28/1993 | CA1322531C Phenolic thioethers as inhibitors of 5-lipoxygenase |
| 09/22/1993 | EP0561523A2 Sugar compound, sialic acid-containing sugar chains' biosynthesis inhibitor, production process thereof and intermediate |
| 09/22/1993 | EP0561166A1 Aerosol compositions containing compound D-18024 and its analogs |
| 09/22/1993 | EP0561034A2 Direct molecular cloning of a modified eukaryotic cytoplasmic DNA virus genome |
| 09/22/1993 | EP0560929A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity |
| 09/22/1993 | EP0474712B1 Lysolecithin derivatives for treating autoimmune diseases |
| 09/22/1993 | EP0247071B1 Immunotherapeutic treatment |
| 09/22/1993 | CN1076453A Novel cyclosporins |
| 09/21/1993 | US5247076 Imidazolidyl macrolides having immunosuppressive activity |
| 09/21/1993 | US5246966 Substituted alkenoic acid and its derivatives |
| 09/21/1993 | US5246951 Nonsteroidal antiinflammatory agents |
| 09/21/1993 | CA1322374C Substituted di-t-butylphenols |
| 09/21/1993 | CA1322367C Thienotriazolodiazepine compounds and pharmaceutical uses thereof |
| 09/19/1993 | CA2091874A1 Triazolopyridazine compounds, their production and use |
| 09/18/1993 | CA2091713A1 Dosage aerosols containing the active substance flezelastin and related structures |
| 09/16/1993 | WO1993018161A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | WO1993018061A1 Immunostimulatory agent |
| 09/16/1993 | WO1993018054A2 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/16/1993 | WO1993018049A1 Fluorosugar derivatives of macrolides |
| 09/16/1993 | WO1993018048A1 2-aminosugar derivatives of macrolides |
| 09/16/1993 | WO1993018042A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 09/16/1993 | WO1993018024A1 1-alkoxy-2-(alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 09/16/1993 | WO1993018006A1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
| 09/16/1993 | WO1993018003A1 Substitued pipecolinic acid derivatives as hiv protease inhibitors |
| 09/16/1993 | WO1993017712A2 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 09/16/1993 | WO1993017700A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 09/16/1993 | WO1993017699A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | WO1993017698A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
| 09/16/1993 | WO1993017671A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 09/16/1993 | WO1993017666A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 09/16/1993 | WO1993016087A3 Amadori reaction compounds and products, process for their manufacture, and their use |
| 09/16/1993 | CA2131524A1 Use of interleukin-10 to suppress graft-vs.-host disease |
| 09/16/1993 | CA2131458A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 09/16/1993 | CA2131371A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 09/16/1993 | CA2131299A1 Lymphocyte activity regulation by hla peptides |
| 09/16/1993 | CA2131150A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 09/16/1993 | CA2131024A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria |
| 09/16/1993 | CA2130938A1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 09/15/1993 | EP0560389A1 Lactone with immunosuppressive activity |
| 09/15/1993 | EP0560275A1 Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients |
| 09/15/1993 | EP0560268A1 Substituted pipecolinic acid derivatives as HIV protease inhibitors |
| 09/15/1993 | EP0559728A1 Aromatic aldehydes and derivatives and pharmaceutical compositions thereof useful for the treatment of skin diseases and arthritis |
| 09/15/1993 | EP0559695A1 New pyridine derivatives, methods of preparing them and their use as drugs. |
| 09/15/1993 | EP0419610B1 New leukotriene b4 derivatives, process for producing them and their use as drugs |
| 09/14/1993 | US5244662 Medicinal extract from a mixture of phellodendron and defatted seed of croton, and method for it's manufacture |
| 09/14/1993 | CA1322158C Uses of recombinant colony stimulating factor-1 |
| 09/12/1993 | WO1993024506A1 IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWISC AND LacNAc COMPOUNDS |
| 09/12/1993 | CA2118405A1 Immunosuppressive and tolerogenic modified lewisc and lacnac compounds |
| 09/08/1993 | EP0559428A2 Novel polypeptides and DNAs encoding them |
| 09/08/1993 | EP0559238A1 New derivative of cyano crotonamide as medicament with immunomodulating properties |
| 09/08/1993 | EP0559055A1 N-Deacetyl lysogangliosides for use as medicaments |
| 09/08/1993 | EP0558677A1 Biologically active amines |
| 09/08/1993 | EP0558659A1 Tnf inhibitors |
| 09/08/1993 | EP0558630A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0558603A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0505353B1 Fast printer with a particle trap in the paper channel |
| 09/08/1993 | CN1075959A Pyrazole derivatives processes for preparation thereof and pharmaceutical composition comprising the same |
| 09/08/1993 | CN1022023C Process for liquid pharmaceutical composition containing piperidinoalkanol derivatives |
| 09/08/1993 | CA2091105A1 Aminocarboxylic acid derivatives with antiallergic/antiasthmatic effect and a process for their preparation |
| 09/07/1993 | US5243094 Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them |
| 09/07/1993 | US5242945 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
| 09/07/1993 | US5242937 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| 09/07/1993 | US5242930 Tachykinin antagonists; nervous system disorders, anxiolytic agents |
| 09/07/1993 | US5242912 Cyclic anthranilic acid derivatives and process of preparing the same |
| 09/07/1993 | CA1322076C Phosphorus containing peptides |
| 09/07/1993 | CA1322005C Benzoheterazoles |
| 09/07/1993 | CA1322004C Pyridyl styrene dialkanoic acids |
| 09/07/1993 | CA1321994C Acylated uridine and cytidine and uses thereof |
| 09/07/1993 | CA1321993C Substituted n-glycosylamides, process for their preparation, and their use as medicaments |
| 09/04/1993 | CA2090639A1 Polypeptides and dnas encoding them |
| 09/02/1993 | WO1993017122A1 Protein with novel pharmacological characteristic |
| 09/02/1993 | WO1993017095A1 In vitro activation of cytotoxic t cells |
| 09/02/1993 | WO1993017044A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections |
| 09/02/1993 | WO1993017043A1 Methods and compounds for prevention of graft rejection |
| 09/02/1993 | WO1993017013A1 Quinolylbenzofuran derivatives as leukotriene antagonists |
| 09/02/1993 | WO1993016978A1 Ketotricyclo(5.2.1.0)decane derivates |
| 09/02/1993 | WO1993016727A1 Mycobacterium vaccae for treatment of long term autoimmune conditions |
| 09/02/1993 | WO1993016725A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | WO1993016724A1 Bystander suppression of autoimmune diseases |
| 09/02/1993 | WO1993016706A1 Use of substituted adenine derivatives for treating multiple sclerosis |
| 09/02/1993 | WO1993016703A1 Protein kinase c inhibitor |
| 09/02/1993 | WO1993016674A1 CoA-IT AND PAF INHIBITORS |
| 09/02/1993 | WO1993014767A3 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections |
| 09/02/1993 | WO1993014760A3 Methods |
| 09/02/1993 | CA2130997A1 Early antigen for autoimmune diabetes |
| 09/02/1993 | CA2130802A1 Methods and compounds for prevention of graft rejection |